Fmoc-(S)-4-chlorophenyl-beta-phenylalanine is a non-natural, protected amino acid derivative. Its structure features a beta-phenylalanine backbone with a 4-chlorophenyl substituent on the beta-carbon and an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group. This configuration imparts specific steric and electronic properties to the molecule. This compound is primarily employed as a specialized building block in solid-phase peptide synthesis (SPPS), particularly using the Fmoc strategy. The Fmoc group is readily cleaved under mild basic conditions, allowing for the sequential assembly of peptide chains. The incorporation of the (S)-4-chlorophenyl-beta-phenylalanine residue is designed to introduce conformational constraints, enhance lipophilicity, and potentially improve metabolic stability or receptor binding affinity in the target therapeutic peptides. It is a key intermediate in the research and development of novel peptide-based drugs, including enzyme inhibitors and receptor modulators. As a structurally defined, protected amino acid, it is also categorized as a fine organic synthesis building block. Its use is confined to specialized research and development laboratories focusing on peptide chemistry and medicinal chemistry.